The review, conducted by Mingyu Liao of Southwest University, Yue Gu of the First Affiliated Hospital of Chongqing Medical University, and Keyin Liu of Civil Aviation Flight University of China, pooled data from thirty-six randomized controlled trials encompassing 3,811 participants. The researchers searched PubMed, Embase, CINAHL, Web of Science, and the Cochrane Library from their inception through 17 December 2025, with an updated search on 19 July 2026, and also combed clinical trial registries including ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform. Only randomized trials comparing digital health interventions against usual care or conventional rehabilitation were eligible, a design choice that places the analysis at the top of the evidence hierarchy for questions of treatment efficacy. The protocol was prospectively registered with PROSPERO, and the team assessed risk of bias with the Cochrane RoB 2 tool and graded the certainty of evidence using the GRADE framework—methodological rigor that lends weight to the findings.

The primary outcomes the investigators tracked reflect the core goals of post-arthroplasty recovery: pain intensity, the total score on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), knee flexion and extension range of motion, and performance on the Timed Up and Go test, a widely used functional measure of mobility and fall risk. Because the constituent trials measured these outcomes on different scales, the team expressed pooled effects as standardized mean differences, or SMDs, using random-effects models that acknowledge the statistical heterogeneity expected when interventions and comparators vary across studies. Subgroup analyses and univariable meta-regression were then deployed as post hoc exploratory tools to probe whether effects differed according to the dominant delivery modality, the duration of follow-up, or the geographic region where the trial was conducted.

The headline results are nuanced rather than triumphant. Digital health interventions produced a statistically significant advantage over conventional rehabilitation on two of the five primary outcomes. The pooled SMD for the WOMAC total score was −0.33 (95% confidence interval −0.59 to −0.06), favoring the digital approach, and knee flexion range of motion showed a pooled SMD of 0.30 (95% confidence interval 0.12 to 0.48), also in favor of digital delivery. For readers unfamiliar with the metric, an SMD of roughly 0.2 is conventionally considered small, 0.5 moderate, and 0.8 large, so both of these effects sit in the small-to-modest range. No statistically significant pooled differences emerged for pain, knee extension range of motion, or Timed Up and Go performance, meaning the digital interventions did not demonstrably outperform standard care on those measures across the aggregated trials.

Perhaps the most scientifically candid element of the paper is what the authors say about the clinical importance of their own findings. Although the WOMAC and flexion results reached statistical significance, the pooled SMDs were not translated into absolute changes on familiar clinical scales, and they were not evaluated against established minimal clinically important difference thresholds—the benchmarks patients and clinicians actually use to judge whether a change is meaningful in daily life. In plain terms, a statistically detectable improvement is not automatically a noticeable one. The authors conclude that the clinical importance of these effects remains uncertain, a caveat that should temper enthusiasm among clinics considering wholesale adoption of digital rehabilitation platforms on the basis of this evidence alone.

Certainty of evidence, as graded by GRADE, ranged from very low to moderate across outcomes, and critically, the two statistically significant findings were supported only by low-certainty evidence. This matters because GRADE downgrades confidence for limitations such as risk of bias, inconsistency, imprecision, and indirectness, and the trials in this field exhibit all of the above to varying degrees. The authors also flag substantial heterogeneity across the interventions themselves—some trials tested telerehabilitation with remote therapist supervision, others mobile applications delivering home exercise programs, others extended reality systems—alongside considerable variation in what the comparator groups actually received. When both the treatment and the control arm differ so widely from study to study, the pooled estimate becomes an average of averages, useful for detecting directional signals but limited in its generalizability to any specific clinical scenario.

The post hoc exploratory analyses, examining variation by delivery modality, follow-up duration, and geographic region, reflect an attempt to untangle that heterogeneity, though the authors frame them explicitly as exploratory rather than confirmatory. This is an appropriate statistical posture: subgroup findings in meta-analyses are prone to false-positive discovery, particularly when the number of trials within each subgroup is small. What the exploratory framework does offer is a roadmap for future primary research, highlighting which delivery formats, time horizons, and care contexts appear most promising and therefore merit adequately powered, pragmatically designed randomized trials with standardized comparators and pre-specified clinically important thresholds.

The practical takeaway offered by the authors is measured and clinically sensible: digital rehabilitation should be considered an adjunct to, rather than a replacement for, conventional rehabilitation after total knee arthroplasty. This framing aligns with the broader trajectory of digital health evidence across surgical specialties, where technology-mediated care most reliably adds value when it augments—rather than substitutes for—hands-on clinical expertise. For a procedure performed hundreds of thousands of times annually worldwide, even small improvements in flexion range of motion and patient-reported function, if confirmed as clinically meaningful, could translate into substantial aggregate benefit, particularly for patients in rural or underserved areas where in-person therapy access is limited. But the review’s own limitations mean that promise remains provisional.

What makes this study notable in the crowded field of digital health meta-analyses is its discipline. Rather than declaring victory for telerehabilitation, the authors report the null findings for pain, extension, and Timed Up and Go performance with the same prominence as the positive ones, quantify their uncertainty honestly, and resist the temptation to convert small standardized effects into bold clinical claims. As health systems worldwide grapple with aging populations, rising demand for joint replacement, and workforce shortages in rehabilitation services, evidence of this caliber—registered, rigorously graded, and transparently caveated—provides exactly the foundation needed for rational policy. The next step is clear: large, well-designed trials that measure absolute clinically important change, standardize comparator care, and determine which patients benefit most from which digital tools. Until then, the smartphone in the recovery room remains a promising assistant, not yet a proven substitute for the therapist’s hands.

Subject of Research: Effects of digital health interventions on rehabilitation outcomes after total knee arthroplasty

Article Title: Effects of digital health interventions in total knee arthroplasty: a systematic review and meta-analysis

Article References: Liao, M., Gu, Y., & Liu, K. (2026). Effects of digital health interventions in total knee arthroplasty: a systematic review and meta-analysis. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15640-6

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15640-6

Keywords: total knee arthroplasty, digital health, telerehabilitation, meta-analysis, randomized controlled trials, WOMAC, range of motion, rehabilitation, mobile applications, virtual reality, physical therapy, evidence certainty

The instrument, called the Chinese Total Knee Arthroplasty Patient-reported Outcome Measurement, or CTP, belongs to a class of questionnaires known as patient-reported outcome measures, or PROMs. Instead of relying on clinicians to grade range of motion on an X-ray or flexion angle with a goniometer, PROMs ask patients directly about pain, function, mood, and quality of life. Proponents argue this approach captures the outcomes that matter most, improves communication between doctor and patient, and detects meaningful improvement that physician-scored measures can overlook. Yet the field has a persistent blind spot: most widely used knee PROMs, including the Oxford Knee Score, the new Knee Society Score, and the WOMAC index, were developed in Western populations and only later adapted for Chinese speakers, often with limited attention to whether the underlying activities and social situations are actually relevant to the people answering them.

The stakes are enormous. Symptomatic knee osteoarthritis affects roughly 14.6 percent of adults in China, and the number of total knee replacement procedures grew at an annual rate of 27.43 percent between 2012 and 2019. Despite this surge, between 10 and 20 percent of patients report dissatisfaction after surgery, a figure that suggests recovery is not simply a matter of a technically flawless implant. The research team’s earlier searches of PubMed, Embase, Scopus, and major Chinese databases found no previously validated, de novo, multidomain PROM built specifically for Chinese knee replacement patients — a gap the new study set out to fill.

The project unfolded in stages. In prior qualitative work, the investigators built an initial pool of 135 candidate items through patient interviews, concept elicitation with a multidisciplinary panel of 17 joint surgeons, orthopedic nurses, rehabilitation therapists, statisticians, and psychologists, two rounds of Delphi expert consultation, and cognitive debriefing with patients. That process produced a six-domain, 35-item preliminary questionnaire. The new study then put the instrument through quantitative refinement across three sequential, independent cohorts totaling 1,748 participants recruited between June 2023 and June 2024, with twelve-month follow-up completed by June 2025. No patient appeared in more than one cohort, a design choice that strengthens the validity of each analytic phase.

The item-reduction statistics tell a striking story about cultural fit. Questionnaires only work if the answers spread out; if nearly everyone gives the same response, the item carries almost no information. Three items asking about preoperative expectations showed ceiling concentrations of 94.7, 84.7, and 56.7 percent, meaning the vast majority of patients gave the top answer, and the entire expectations domain was dropped. A jogging item floored at 71.7 percent ceiling, while questions about embarrassment when others see the knee produced floor effects. At the same time, activities central to Chinese daily life — squatting, rising from low seating without armrests, mild field labour, climbing stairs in buildings without elevators, and community exercise such as Tai Chi or square dancing — loaded strongly onto the scale and stayed in. The result is a final 22-item clinical questionnaire with ten bilateral symptom items, eight function items, three quality-of-life items, and a single global satisfaction question.

For the formal psychometric testing, the team concentrated on a 16-item operated-knee core score covering symptoms, function, and quality of life, deliberately scoring only the replaced joint to avoid contamination from the other arthritic knee. The reliability figures were impressive. Cronbach’s alpha, a measure of internal consistency that reflects how coherently items hang together, reached 0.864 for the total core score, with subscale values between 0.809 and 0.942. When 150 participants filled out the questionnaire twice, two weeks apart and before any surgery, the intraclass correlation coefficient was 0.836, indicating that scores are stable over time rather than bouncing with mood or measurement noise.

Validity results were more nuanced. Exploratory factor analysis on a random half of the final cohort supported a clean three-factor structure matching Symptoms, Function, and Quality of Life, with all items loading above 0.40 and the three factors together explaining 72.2 percent of variance. But confirmatory factor analysis on the other half told a partially different story: absolute fit indices such as the SRMR (0.05), RMSEA (0.04), and the chi-square ratio (2.13) met prespecified thresholds, while the comparative fit index (0.92) and non-normed fit index (0.91) fell just short of the strict 0.95 criterion. The authors are candid about this, describing the structure as receiving partial rather than uniform support that requires independent replication — an unusually honest framing in a literature where fit indices are sometimes selectively reported.

The team also benchmarked the new measure against WOMAC, the most entrenched Western instrument. Convergent validity was strong where constructs genuinely overlap: the CTP function domain correlated with WOMAC function at r = 0.698, and CTP symptoms tracked WOMAC pain at r = 0.605, exactly the pattern expected if both instruments are measuring the same underlying phenomena. The weak correlation (r = 0.355) between CTP quality of life and WOMAC stiffness was not a failure but a confirmation that the two domains are conceptually distinct — stiffness is not a proxy for life satisfaction. Most importantly, in the responsiveness analysis, the CTP total score dropped from 33.52 at baseline to 21.81 one year after surgery, an effect size of 1.34 and a standardised response mean of 1.66, both comfortably in the large-effect range. WOMAC produced even larger standardised changes, but the authors caution that effect-size magnitude depends on an instrument’s content and score distribution and should not be read as a head-to-head superiority contest. What the CTP offers is complementary coverage of symptoms, psychosocial impact, and culturally salient activities that WOMAC simply does not ask about.

The study’s limitations are clearly acknowledged. All three hospitals were tertiary centres in western China, so the findings establish multicentre evidence within that region rather than nationwide generalisability; dialect, occupation, healthcare access, and community habits vary considerably across the country. No recognised Chinese gold-standard knee PROM existed, making criterion validity impossible to assess, and the quality-of-life domain still awaits validation against independent generic health or mental-health measures. Future work, the authors write, should test measurement invariance across diverse regions, establish anchor-based interpretability thresholds so that clinicians know what a given score change actually means, and evaluate whether the CTP adds predictive information beyond established instruments.

Even so, the implications reach well beyond orthopedics. Roughly half of the participants reported primary education or less, and nearly three-quarters relied on rural cooperative medical insurance — populations routinely underrepresented in instrument development. The CTP demonstrates that a psychometrically sound measure can be built from patient interviews upward, tested in more than 1,700 real patients across multiple centres, and refined with transparent statistical criteria rather than ad hoc judgment. It takes patients an average of under five minutes to complete. As knee replacement volumes continue their steep climb in China and across Asia’s aging societies, the study makes a forceful case that outcome measurement should be grounded in the lives patients actually lead — whether that means a walk around a Western suburb or a deep squat in a courtyard garden. The questionnaire does not replace WOMAC and its peers, but it may finally ask the right questions of the people answering them.

Subject of Research: Development and multicentre psychometric validation of a culturally tailored patient-reported outcome measure for Chinese total knee arthroplasty patients

Article Title: Quantitative refinement and multicentre psychometric validation of the Chinese total knee arthroplasty patient-reported outcome measure: a prospective cohort study with repeated measures

Article References: Xu, C., Chang, X., Ye, F., Wu, H., Chen, G., Zhang, R., Yao, S., Shang, L., & Ma, J. (2026). Quantitative refinement and multicentre psychometric validation of the Chinese total knee arthroplasty patient-reported outcome measure: a prospective cohort study with repeated measures. The Lancet Regional Health – Western Pacific, 74, Article 101989. https://doi.org/10.1016/j.lanwpc.2026.101989

Image Credits: AI Generated

DOI: 10.1016/j.lanwpc.2026.101989

Keywords: total knee arthroplasty, patient-reported outcome measures, psychometric validation, knee osteoarthritis, Cronbach's alpha, WOMAC, cross-cultural adaptation, responsiveness, factor analysis, China, orthopedic surgery, quality of life

The research, published in BMC Medical Imaging, was designed as an exploratory prospective paired study, meaning each patient served as their own control. Between October 2024 and June 2025, the team enrolled 96 patients who had undergone total knee arthroplasty and presented for routine postoperative follow-up with digital radiography, the workhorse imaging modality for post-arthroplasty surveillance. For each participant, standard anteroposterior and lateral radiographs of the replaced knee were acquired, and the raw images were then processed twice: once left in their original form, and once reconstructed using the EVP Plus metal artifact reduction algorithm. Because both versions of every image came from the same acquisition, the comparison isolated the effect of the software itself, eliminating confounders such as patient anatomy, positioning, and exposure settings.

The physics behind the problem is well understood. Metal implants attenuate X-rays far more strongly than cortical bone, cancellous bone, or soft tissue, and their polished surfaces can redirect photons in ways the detector never anticipates. The result is a combination of photon starvation, where too few X-rays reach the detector behind the implant, and scatter-induced noise, which degrades the signal in the adjacent regions. Beam hardening and edge effects add streaks and bright halos that can mimic or mask pathology. In the peri-implant zone—exactly where radiologists need to look for loosening lines, osteolysis, infection-related lucencies, and periprosthetic fractures—these artifacts are most severe. Computed tomography offers metal artifact reduction algorithms of its own, but CT is costly, delivers a higher radiation dose, and introduces its own metal-induced artifacts, which is why plain radiography remains the first-line follow-up tool globally.

EVP Plus approaches the problem as a post-processing reconstruction task applied to the digital radiograph itself. Rather than requiring new hardware or repeat exposures, the algorithm analyzes the raw image data, identifies the regions degraded by metal-induced noise and scatter, and applies correction strategies that suppress the artifact while preserving anatomical detail. The study’s authors evaluated the technology with a two-pronged assessment: objective measurements computed from pixel data, and subjective evaluations performed by observers reviewing the images on a picture archiving and communication system.

The objective results were statistically robust. In a defined region of interest placed in the tissue adjacent to the implant, the processed images showed a significant reduction in noise values compared with the original radiographs. Because noise fell while the underlying signal was retained, the signal-to-noise ratio increased markedly in the EVP Plus reconstructions. All of these objective differences reached the stringent threshold of P less than 0.001, indicating an extremely low probability that the observed improvements arose by chance. Notably, the contrast-to-noise ratio between the region of interest and the adjacent bone and soft tissue decreased after processing. The researchers interpret this pattern as the expected signature of effective artifact suppression: the algorithm reduces the artificially extreme contrast created by metal artifacts, evening out the image so that genuine anatomical structures rather than artifact-induced extremes dominate the visual field.

Subjective image quality assessment reinforced the quantitative findings. Observers rated the processed images as superior for visualizing peri-implant anatomy, with clearer depiction of the bone-implant interface and the surrounding soft tissue envelope. The reduction in streaking and shadowing allowed reviewers to trace cortical outlines and trabecular patterns closer to the prosthesis than was possible on the original images, where the implant’s footprint on the radiograph extended well beyond its physical edges.

Perhaps the most clinically consequential result concerned lesion detectability. When the researchers evaluated the images for the detection of clinical lesions in the peri-implant region, the processed images achieved a significantly higher lesion detection rate than the originals, with the difference reaching statistical significance at P less than 0.05. In practical terms, this means that abnormalities that could be missed or ambiguously visualized on conventional radiographs became identifiable after EVP Plus processing. For postoperative surveillance, that difference matters: periprosthetic joint infection, aseptic loosening, and periprosthetic fractures each demand timely diagnosis, and radiographs are typically the first test ordered when a patient reports new pain, swelling, or instability in a replaced knee. An imaging improvement that raises the detection rate on the first-line study could translate into earlier diagnosis, fewer follow-up imaging rounds, and reduced reliance on more expensive cross-sectional imaging.

The study’s design carries both strengths and limitations worth noting. The paired, self-controlled structure of the 96-patient cohort lends internal validity, since each image pair shares identical acquisition conditions, and the concurrent use of subjective and objective metrics addresses the well-recognized gap that can open between pixel statistics and radiologist perception. As an exploratory, single-center study, however, its findings await confirmation in larger, multicenter cohorts, and the specific performance of EVP Plus may vary with detector technology, exposure protocols, and implant designs used at other institutions. The authors also acknowledge that radiography-based artifact reduction cannot fully replicate the three-dimensional information provided by CT, meaning the technology refines rather than replaces the existing imaging pathway.

Even so, the implications for routine practice are substantial precisely because the intervention is software-only. No additional radiation dose is delivered, no new equipment must be purchased beyond a software upgrade, and the processing can be integrated into the standard workflow between acquisition and interpretation. In health systems where the volume of arthroplasty is rising sharply—driven by aging populations and the expanding indications for joint replacement—the marginal cost of applying metal artifact reduction to every follow-up radiograph is minimal compared with the potential savings from avoided CT scans and earlier detection of complications. The study was supported by the Gansu Provincial Health Industry Research Plan for Excellent Young Talents and Backbone Talents Project, the Gansu Provincial Natural Science Foundation, and the Cuiying Graduate Supervisor Training Program of the Second Hospital of Lanzhou University, and it was conducted under ethics approval with written informed consent from all participants or their legal guardians.

As artificial intelligence and advanced image reconstruction continue to migrate into mainstream radiology, this study offers a concrete example of how computational correction can reclaim diagnostic information that hardware limitations once surrendered. For patients with total knee replacements, the radiograph that once showed a bright metal silhouette wreathed in streaks may soon deliver a genuinely readable view of the bone and tissue that matter most—the very structures that reveal whether their new joint is failing or thriving. The Lanzhou team’s conclusion is straightforward: through effective artifact suppression, improved image quality, and enhanced peri-implant lesion detection, DR metal artifact reduction demonstrates significant clinical value in the aftermath of total knee arthroplasty, and it may be poised to become a routine component of post-arthroplasty imaging worldwide.

Subject of Research: Evaluation of digital radiography metal artifact reduction technology for postoperative imaging after total knee arthroplasty

Article Title: The application value of DR metal artifact reduction technology in total knee arthroplasty

Article References: The application value of DR metal artifact reduction technology in total knee arthroplasty. (n.d.). https://doi.org/10.1186/s12880-026-02759-5

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02759-5

Keywords: total knee arthroplasty, metal artifact reduction, digital radiography, EVP Plus, image quality, signal-to-noise ratio, contrast-to-noise ratio, peri-implant lesion detection, medical imaging, radiography, periprosthetic complications, image processing